BARBARA NOAH

Date Type Title Author Work Cited To/Mentioned In/Quoted In Citation (including footnote number)
January/February 2013 bibliography Keeping current--Probate N/A The role of race in end-of-life care, 15 J. Health Care L. & Pol'y 349 (2012) Literature section: 27-FEB Prob. & Prop. 26 (2013)
October-December 2012 law review footnote Prisoner participation in clinical research trials: A fundamental right under the Eighth Amendment? Vivian Lee The participation of underrepresented minorities in clinical research, 29 Am. J. L. & Med. 221 (2003) Footnotes 34, 36: 33 J. Legal Med. 541 (2012)
September 17, 2012 working paper citation Patients to peers: Barriers and opportunities for doctors with disabilities Alicia Ouellette A prescription for racial equality in medicine, 40 Conn. L. Rev. 675 (2008) Footnotes 99, 104: http://ssrn.com/abstract=2147902 (2012)
July 2012 law review footnote A phantom recall does not comport with FDA's regulatory practice-- or does it?: The need for more stringent mandatory reporting in FDA matters Eleanor G. Tennyson Adverse drug reactions: Harnessing experiential data to promote patient welfare, 49 Cath. U. L. Rev. 449 (2000) Footnotes 117, 126, 128, 129: 97 Iowa L. Rev. 1839
June 2012 law review footnote The regulation of race in science Kimani Paul-Emile The participation of underrepresented minorities in clinical research, 29 Am. J. L. & Med. 221 (2003) Footnotes 12, 18, 37, 48, 51: 80 Geo. Wash. L. Rev. 1115 (2012)
Summer 2012 book review  footnote The toxicity of low-dose chemical exposures: A status report and a proposal Mary L. Lyndon Bioethical malpractice: Risk and responsibility in human research, 7 J. Health Care L. & Pol'y 175 (2004) Footnote 181:52 Jurimetrics J. 457 (2012)
Spring 2012 law review footnote Regulation of drugs: A death sentence for the terminally ill? Priya Brandes Bioethical malpractice: Risk and responsibility in human research, 7 J. Health Care L. & Pol'y 175 (2004) Footnotes 43, 154-158, 190: 46 U.S.F. L. Rev. 1149 (2012)
Spring 2012 law review footnote Follow the money: Insulating agribusiness through lobbying and suppression of individual free speech Mallorie McCue Liberating commercial speech: Product labeling controls and the First Amendment, 47 Fla. L. Rev. 63 (1995) (with Lars Noah) Footnote 41: 6 Pitt. J. Envtl Pub. Health L. 213 (2012)
February 1, 2012 newspaper article The FDA's efforts to regulate dietary supplements, then and now                  Theodora McCormick                The dietary supplement health and education act: Regulation at a crossroads, 31 American Journal of Law and Medicine 147 (2005) Footnotes 1, 9: 2/01/12 Metro. Corp. Couns. 36 (2012)
Winter 2012 law review footnote Statistical considerations support the Supreme Court’s Decision in Matrixx Initiatives v. Siracusano Joseph L. Gastwirth Adverse drug reactions: Harnessing experiential data to promote patient welfare, 49 Cath. U. L. Rev. 449 (2000) Footnotes 6, 96,111: 52 Jurimetrics J. 155 (2012)
Winter 2012 law review footnote Drug development-stuck in a state of puberty?: Regulatory reform of human clinical research to raise responsiveness to the reality of human variability Michael J. Malinowski & Grant G. Gautreaux Just a spoonful of sugar: Drug safety for pediatric populations, 37 J.L. Med. & Ethics 280 (2009) Footnote 17: 56 St. Louis L.J. 363 (2012)
Winter 2012 law review footnote Painting beyond the numbers: The art of providing inclusive law school admission to ensure full representation in the profession Paula Lustbader A prescription for racial equality in medicine, 40 Conn. L. Rev. 675 (2008) Footnote 315: 40 Cap. U. L. Rev. 71 (2012)
2012 law review footnote Accountable care organizations: Can we have our cake and eat it too? Jessica L. Mantel Racial disparities in the delivery of health care, 35 San Diego L. Rev. 135 (1998) Footnote 222: 42 Seton Hall L. Rev. 1393 (2012)
Winter 2011 law review footnote The management of health care costs: Independent medical review after "Obamacare" Dustin D. Berger The managed care dilemma: Can theories of tort liability adapt to the realities of cost containment?, 48 Mercer L. Rev. 1219 (1997) Footnote 130: 42 U. Mem. L. Rev. 255 (2011)
Fall 2011 law review footnote Academic treatment of abortion and euthanasia in leading bioethics textbooks Prolife Center at the University of St. Thomas Law, medicine, and medical technology (2002) (with Lars Noah) Footnotes 2, 3: 6 U. St. Thomas J. L. & Pub. Pol'y 54 (2011)
2011 annotated statute FL Bar Probate Rules §§ 765.101, 765.104, 765.105, 765.302, 765.401, 765.404 N/A Politicizing the end of life: Lessons from the Schiavo controversy, 59 U. Miami L. Rev. 107 (2004) Annotation under "Law Reviews"